Sunesis Pharmaceuticals Stock Predictions

Buy SNSS

*Your capital is at risk

$5.32

+0 (+0%)

At Close: May 27, 2022

Currently predicting for Mon, 15 Jun 2026

SNSS Live board

Community Bull/Bear

Target Next close

Join the SNSS prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

SNSS Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For SNSS

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

SNSS Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT SUNESIS PHARMACEUTICALS

Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. The company is developing vosaroxin, an anticancer quinolone derivative for the treatment of acute myeloid leukemia (AML). It has completed a Phase III, randomized, double-blind, and placebo-controlled trial of vosaroxin in combination with cytarabine in patients ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
EAT $140.46	13.43%	Jun 05
TPR $140.47	4.95%	Jun 04
LITE $905.00	1.83%	Jun 01
RUN $12.83	0.468%	May 06
GLBE $31.61	3.54%	May 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by